TickerFacts.

ImageneBio, Inc. (IMA): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$414.0K
Year ended 2023-12-31
-18.5%
3-year compound annual growth
$1.76M2020-12-31: $766.0K2021-12-31: $1.76M2022-12-31: $1.43M2023-12-31: $414.0K$414.0K
2020-12-31 Capital Expenditures (USD) 2023-12-31
Period endedCapital ExpendituresChange YoYSource filing
2023-12-31$414.0K-71.1%2025-03-06, From 2023-01-01
2022-12-31$1.43M-18.7%2024-03-12, From 2022-01-01
2021-12-31$1.76M+129.8%2023-03-14, From 2021-01-01
2020-12-31$766.0Kn/a2022-03-17, From 2020-01-01